Labor hour award center for drug evaluation and research (cder) office of new drugs (OND) - health science support notice to proceed was issued on 06/17/2025 effective 06/19/2025. Contracting…

Active Awarded Last action

Contract number
75F40125F19007
Awardee
Awarding agency
Obligated
$7,282,271

Award facts

Contract value 56% obligated
  • $7,282,271.49 Current, with exercised options
  • $13,045,018.34 Potential, with all options
Completion date 56% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
Competitive 8(a)
Competition
Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
Pricing
Labor Hours
Place of performance
Silver Spring, MD 20993, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00005 · Labor hour award $347,994
Exercise an Option P00004 $5,110,637
Exercise an Option P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $1,823,641

About this award

The Food and Drug Administration issued a delivery order to Kaiva Strategies, LLC, a tribally-owned, minority-owned, 8(a)-certified small business, on June 25, 2025, under the Professional, Administrative, and Consulting Services (PACS) IDIQ with a ceiling value of $13,045,018.34.

The PACS IDIQ is a single-award, competitive 8(a) set-aside vehicle supporting professional, administrative, and consulting services across FDA centers and offices. This delivery order supports the Center for Drug Evaluation and Research Office of New Drugs with health science support services on a labor-hour basis. Place of performance is Silver Spring, Maryland. The notice to proceed was issued June 19, 2025, with ultimate completion scheduled for November 14, 2027. The contracting officer's representative is Shila Ndeh.

Description

Labor hour award center for drug evaluation and research (cder) office of new drugs (OND) - health science support notice to proceed was issued on 06/17/2025 effective 06/19/2025. Contracting officer's representative (COR) shila ndeh

Quick answers

Who was awarded contract 75F40125F19007?

75F40125F19007 was awarded to Kaiva Strategies, LLC by Food and Drug Administration (Department of Health and Human Services) on June 25, 2025.

How much is contract 75F40125F19007 worth?

The government has obligated $7,282,271 on 75F40125F19007. Its potential value, with all options, is $13,045,018.

Is contract 75F40125F19007 an order under another contract?

Yes. 75F40125F19007 is a delivery order under 75F40123D00021, an indefinite delivery contract.

Was contract 75F40125F19007 competed?

The extent of competition for 75F40125F19007 was full and open competition after exclusion of sources. It was set aside: Competitive 8(a).

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award